Probity Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $245K | Sell |
2,713
-262
| -9% | -$24K | 0.04% | 216 |
|
|
2025
Q4 | $268K | Buy |
2,975
+207
| +7% | +$19.6K | 0.04% | 214 |
|
|
2025
Q3 | $273K | Sell |
2,768
-297
| -10% | -$29.4K | 0.04% | 212 |
|
|
2025
Q2 | $280K | Sell |
3,065
-20
| -0.6% | -$1.93K | 0.05% | 201 |
|
|
2025
Q1 | $349K | Sell |
3,085
-116
| -4% | -$12.4K | 0.07% | 180 |
|
|
2024
Q4 | $338K | Sell |
3,201
-247
| -7% | -$26.5K | 0.07% | 183 |
|
|
2024
Q3 | $372K | Sell |
3,448
-53
| -2% | -$5.78K | 0.07% | 181 |
|
|
2024
Q2 | $380K | Sell |
3,501
-33
| -0.9% | -$3.89K | 0.08% | 169 |
|
|
2024
Q1 | $466K | Buy |
3,534
+186
| +6% | +$23.2K | 0.1% | 150 |
|
|
2023
Q4 | $407K | Sell |
3,348
-302
| -8% | -$33.7K | 0.09% | 156 |
|
|
2023
Q3 | $410K | Sell |
3,650
-88
| -2% | -$11.2K | 0.09% | 132 |
|
|
2023
Q2 | $544K | Buy |
+3,738
| New | +$508K | 0.12% | 116 |
|
|
2022
Q4 | $492K | Sell |
3,855
-157
| -4% | -$18.2K | 0.11% | 118 |
|
|
2022
Q3 | $419K | Sell |
4,012
-229
| -5% | -$25.1K | 0.1% | 123 |
|
|
2022
Q2 | $446K | Sell |
4,241
-27
| -0.6% | -$3.2K | 0.1% | 128 |
|
|
2022
Q1 | $546K | Sell |
4,268
-149
| -3% | -$18K | 0.11% | 123 |
|
|
2021
Q4 | $545K | Sell |
4,417
-86
| -2% | -$11.3K | 0.11% | 131 |
|
|
2021
Q3 | $640K | Buy |
4,503
+47
| +1% | +$6.91K | 0.13% | 118 |
|
|
2021
Q2 | $696K | Sell |
4,456
-11
| -0.2% | -$1.78K | 0.15% | 110 |
|
|
2021
Q1 | $694K | Buy |
+4,467
| New | +$692K | 0.16% | 106 |
|
|
2020
Q3 | $620K | Buy |
4,689
+187
| +4% | +$24.4K | 0.18% | 99 |
|
|
2020
Q2 | $522K | Sell |
4,502
-76
| -2% | -$8.76K | 0.16% | 105 |
|
|
2020
Q1 | $449K | Sell |
4,578
-23
| -0.5% | -$3.02K | 0.17% | 106 |
|
|
2019
Q4 | $669K | Sell |
4,601
-93
| -2% | -$12.8K | 0.2% | 92 |
|
|
2019
Q3 | $626K | Buy |
4,694
+21
| +0.4% | +$2.71K | 0.2% | 98 |
|
|
2019
Q2 | $534K | Sell |
4,673
-97
| -2% | -$11.4K | 0.18% | 110 |
|
|
2019
Q1 | $591K | Buy |
4,770
+68
| +1% | +$7.73K | 0.2% | 96 |
|
|
2018
Q4 | $473K | Sell |
4,702
-389
| -8% | -$43.7K | 0.18% | 99 |
|
|
2018
Q3 | $650K | Sell |
5,091
-5
| -0.1% | -$595 | 0.21% | 90 |
|
|
2018
Q2 | $551K | Buy |
5,096
+110
| +2% | +$12K | 0.19% | 96 |
|
|
2018
Q1 | $528K | Buy |
4,986
+131
| +3% | +$15.2K | 0.18% | 96 |
|
|
2017
Q4 | $569K | Sell |
4,855
-283
| -6% | -$32K | 0.2% | 92 |
|
|
2017
Q3 | $584K | Sell |
5,138
-55
| -1% | -$6.35K | 0.22% | 81 |
|
|
2017
Q2 | $647K | Buy |
5,193
+331
| +7% | +$39.2K | 0.24% | 79 |
|
|
2017
Q1 | $576K | Sell |
4,862
-167
| -3% | -$18.9K | 0.22% | 84 |
|
|
2016
Q4 | $504K | Sell |
5,029
-32
| -0.6% | -$3.43K | 0.21% | 87 |
|
|
2016
Q3 | $639K | Sell |
5,061
-41
| -0.8% | -$5.07K | 0.28% | 74 |
|
|
2016
Q2 | $596K | Buy |
+5,102
| New | +$577K | 0.27% | 75 |
|
Other funds holding ZBH
VCM
VPM
Probity Advisors's ZBH Position: Q1 2026 in Review
Probity Advisors reduced its Zimmer Biomet (ZBH) stake by 8.8% in Q1 2026, selling an estimated $24K and leaving 2,713 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #216.
Probity Advisors first reported a position in ZBH in Q2 2016 and has held it in 38 quarters since. The position peaked at $696K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Probity Advisors held 2,713 shares of Zimmer Biomet worth $245K as of Q1 2026.
- Probity Advisors sold 262 Zimmer Biomet shares in Q1 2026, an estimated $24K.
- Zimmer Biomet made up 0.04% of Probity Advisors's portfolio in Q1 2026, its #216 holding.
- Probity Advisors first reported a position in Zimmer Biomet in Q2 2016 and has held it in 38 quarters since.
- Probity Advisors's Zimmer Biomet position peaked at $696K in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.